Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alexandra Giatromanolaki, Alison H. Banham, Adrian L. Harris & Michael I. Koukourakis. (2019) FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma. Experimental Lung Research 45:3-4, pages 76-83.
Read now
Read now
Hideki Ujiie, Kyuichi Kadota, Jun-ichi Nitadori, Joachim G Aerts, Kaitlin M Woo, Camelia S Sima, William D Travis, David R Jones, Lee M Krug & Prasad S Adusumilli. (2015) The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers. OncoImmunology 4:6.
Read now
Read now
Florine Obrist, Gwenola Manic, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2015) Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology 2:2.
Read now
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Aurélien Marabelle, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. OncoImmunology 4:4.
Read now
Read now
David Heigener & Martin Reck. (2015) Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancer. Expert Review of Anticancer Therapy 15:1, pages 69-83.
Read now
Read now
Articles from other publishers (8)
Chihiro Yoshida, Kyuichi Kadota, Toshihiro Ikeda, Emi Ibuki, Tetsuhiko Go, Reiji Haba & Hiroyasu Yokomise. (2021) Tumor-associated macrophage infiltration is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas. Lung Cancer 158, pages 91-96.
Crossref
Crossref
Pournima Kadam, Ram P. Singh, Michael Davoodi, Jay M. Lee, Maie St. John & Sherven Sharma. (2020) Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine. Vaccines 8:4, pages 655.
Crossref
Crossref
Alexandra Giatromanolaki, Adrian L. Harris, Alison H. Banham, Constantinos A. Contrafouris & Michael I. Koukourakis. (2020) Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltration. British Journal of Cancer 122:8, pages 1205-1210.
Crossref
Crossref
Yuanmei Dong, Yang Liu, Hui Bai & Shunchang Jiao. (2019) Systematic assessment of the clinicopathological prognostic significance of tissue cytokine expression for lung adenocarcinoma based on integrative analysis of TCGA data. Scientific Reports 9:1.
Crossref
Crossref
Lingyan Wang, Bijun Zhu, Miaomiao Zhang & Xiangdong Wang. (2017) Roles of immune microenvironment heterogeneity in therapy-associated biomarkers in lung cancer. Seminars in Cell & Developmental Biology 64, pages 90-97.
Crossref
Crossref
Yanli He, Lihui Wang, Weijun Liu, Jinjie Zhong, Shengbin Bai, Zhuwen Wang, Dafydd G. Thomas, Jules Lin, Rishindra M. Reddy, Nithya Ramnath, Philip W. Carrott, William R. Lynch, Mark B. Orringer, Andrew C. Chang, David G. Beer & Guoan Chen. (2015) MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer. Scientific Reports 5:1.
Crossref
Crossref
Martin Reck & Luis Paz-Ares. (2015) Immunologic Checkpoint Blockade in Lung Cancer. Seminars in Oncology 42:3, pages 402-417.
Crossref
Crossref
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean-Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa Coussens, Madhav V. Dhodapkar, Alexander M. Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Pawel Kalinski, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, Jean-Pierre Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, Anna Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer Rizvi, Catherine Sautès-Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva-Santos, Mark J. Smyth, Daniel E. Speiser, Radek Spisek, Pramod K. Srivastava, James E. Talmadge, Eric Tartour, Sjoerd H. Van Der Burg, Benoît J. Van Den Eynde, Richard Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou & Guido Kroemer. (2014) Classification of current anticancer immunotherapies. Oncotarget 5:24, pages 12472-12508.
Crossref
Crossref